Divi's Laboratories Limited is an Indian pharmaceutical company headquartered in Hyderabad, Telangana. The company is engaged in the manufacture of active pharmaceutical ingredients (APIs), intermediates and nutraceutical ingredients, and is recognised as one of the leading custom synthesis providers to global innovator pharmaceutical companies.
| Name | Divi's Laboratories Limited |
|---|---|
| Industry | Pharmaceuticals |
| Founder | Murali Krishna Prasad Divi |
| Headquarters | Hyderabad, Telangana, India |
| Country | India |
| Listings | BSE, NSE |
| Products | Active pharmaceutical ingredients, intermediates, nutraceuticals, custom synthesis |
The company was founded by Murali Krishna Prasad Divi, a pharmacist by training, who had earlier worked in the Indian pharmaceutical industry before starting his own venture. Divi's Laboratories built its business model around two principal segments: a generic API business serving regulated and semi-regulated markets, and a custom synthesis service catering to innovator companies that outsource the manufacture of patented intermediates and APIs.
Divi's Laboratories operates manufacturing facilities in the states of Telangana and Andhra Pradesh, with major units located near Hyderabad and at Visakhapatnam. The company exports a substantial share of its production to markets in Europe, North America and Asia, supplying both bulk APIs and contract manufacturing services. Its product portfolio covers a range of therapeutic categories including cardiovascular, anti-diabetic, anti-inflammatory and central nervous system drugs.
A significant part of the company's revenue is derived from custom synthesis of advanced intermediates and APIs for global innovator pharmaceutical firms. This business has positioned Divi's as a long-standing partner for several multinational drug companies seeking outsourced chemistry and process development.
The company also produces nutraceutical ingredients, including carotenoids and other ingredients used in dietary supplements and food fortification.
Divi's Laboratories is a publicly listed company in India, with its equity shares traded on the Bombay Stock Exchange and the National Stock Exchange of India. It is included among the constituents of major Indian benchmark indices and is regarded as one of the larger Indian pharmaceutical companies by market capitalisation.
Divi's Laboratories is considered an important contributor to India's position as a global supplier of APIs and contract manufacturing services. The company is frequently cited as an example of an Indian firm that has built scale in fine chemicals and process chemistry while serving regulated international markets.